Global Fetal Monitoring Market – Industry Trends and Forecast to 2031

Fetal Monitoring Market Analysis and Size

According to WHO, an estimated 13.4 million babies were born preterm in 2020, which accounts for more than 1 in 10 births worldwide. Preterm birth complications, including respiratory distress syndrome and infections, are the leading cause of death among children under 5 years of age, responsible for approximately 900,000 deaths in 2019. Many survivors face lifelong disabilities, such as learning disabilities and visual and hearing problems. Globally, prematurity is the leading cause of death in children under 5, with survival rates varying significantly between low-income and high-income settings. In low-income settings, half of the babies born at or below 32 weeks die due to a lack of accessible and cost-effective care, including warmth, breastfeeding support, and basic care for infections and breathing difficulties.

The global fetal monitoring market size was valued at USD 3.76 billion in 2023 and is projected to reach USD 6.18 billion by 2031, with a CAGR of 6.40% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Market Definition

Fetal monitoring refers to monitoring the fetal heart rate and other parameters during pregnancy, labor, and delivery. It is used to assess the fetus's well-being and detect any signs of distress or complications. Fetal monitoring can be done using electronic devices that measure the fetal heart rate and uterine contractions, or it can be done through more traditional methods such as auscultation with a stethoscope. Fetal monitoring is an important tool in obstetrics. It can help healthcare providers make decisions about the management of labor and delivery to ensure the best possible outcome for both the mother and the baby.

Fetal Monitoring Market Dynamics

Drivers

• Increasing Maternal Age and Pregnancy-Related Complications

The risk of pregnancy complications, including gestational diabetes, preeclampsia, and placental abnormalities, is increasing with delayed childbirth in today's time. Older maternal age is associated with a higher likelihood of chromosomal abnormalities in the fetus, necessitating more frequent and intensive monitoring throughout pregnancy. Healthcare providers increasingly rely on advanced fetal monitoring technologies to detect and manage these complications early, ensuring the mother's and baby's health and well-being. Increasing maternal age and the rising incidence of pregnancy-related complications are significant drivers boosting the demand for fetal monitoring.

• Rising Prevalence of Fetal Abnormalities and Birth Defects

Factors such as genetic predisposition, maternal age, exposure to environmental toxins, and lifestyle choices contribute to the increased incidence of fetal abnormalities. Fetal monitoring plays a vital role in detecting anomalies such as congenital heart defects, neural tube defects, and chromosomal abnormalities such as Down syndrome. It is crucial to detect these abnormalities early for timely interventions and management, which can improve outcomes for the baby. The rising prevalence of fetal abnormalities and congenital disabilities and importance for early detection is a key driver fueling the demand for fetal monitoring.

Opportunities

• Non-Invasive Prenatal Testing and Monitoring Technologies

NIPT, which involves analyzing cell-free fetal DNA in the mother's blood, offers a safer and more accurate alternative to traditional invasive procedures such as amniocentesis and chorionic villus sampling for detecting chromosomal abnormalities such as Down syndrome. These technologies have changed prenatal care by offering early and dependable information about the fetus, reducing the risk of complications with invasive procedures. As NIPT becomes more widely available and affordable, there is a growing opportunity to expand its use in routine prenatal care, leading to improved outcomes for mothers and babies and driving growth in the market.

• Government Initiatives to Reduce Infant Mortality Rates

Many governments are increasingly focusing on improving maternal and child health outcomes, including reducing the number of stillbirths and neonatal deaths. As part of these initiatives, governments are investing in healthcare infrastructure, promoting prenatal care programs, and advocating for using advanced fetal monitoring technologies. Government initiatives to reduce infant mortality rates present a significant opportunity for the market.

Restraints/Challenges

• High Cost Limits Fetal Monitoring Access

The high cost of advanced fetal monitoring technologies can limit their accessibility and affordability, hindering their adoption in clinical settings. This can result in disparities in access to care, with patients in underserved areas or low-income groups facing challenges in accessing the benefits of these technologies. In addition, the cost of training healthcare professionals to use these devices effectively can also be a barrier, further limiting their impact on improving maternal and fetal health outcomes, which can be a challenge for the market.

• Regulatory Hurdles

Fetal monitoring devices, such as other medical devices, must meet strict rules to ensure they are safe and work well. Understanding these rules, which can vary from country to country, can be complicated and time-consuming, requiring a lot of resources and knowledge. Delays in obtaining regulatory approvals can hinder product launches and market entry, impacting the ability of companies to introduce innovative technologies and meet the needs of healthcare providers and patients, presents a significant challenge for the market.

• Limited Awareness and Education

Many expectant mothers and healthcare providers may not be fully aware of the benefits of fetal monitoring or the range of technologies available. This lack of awareness can result in the underutilization of fetal monitoring devices, leading to missed opportunities for early detection and intervention in pregnancy complications. Moreover, inadequate education and training on using these devices can limit their effectiveness and impact on maternal and fetal health outcomes. Limited awareness and education present a significant challenge for the market.

This fetal monitoring market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the fetal monitoring market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In June 2021, Nuvo Group obtained approval from the United States Food and Drug Administration (FDA) to expand the utility of its INVU platform. INVU, a prescription-initiated remote pregnancy monitoring platform, received approval for a new uterine activity module. This module allows for remote monitoring of uterine activity, enhancing the platform's capabilities
• In May 2021, Medtronic plc introduced the SonarMed airway monitoring system. This system utilizes acoustic technology to continuously assess endotracheal tube obstruction and verify its position in real-time. This provides clinicians with critical information needed to make more informed decisions, particularly for neonates and infants, potentially saving lives

Fetal Monitoring Market Scope

The fetal monitoring market is segmented on the basis of product type, portability, methods, application, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Instruments and Consumables
• Ultrasound
  • 2D Ultrasound
  • 3D Ultrasound
  • 4D Ultrasound
  • Doppler Imaging
• Electronic Maternal/Fetal Monitor
  • External Monitors
  • Internal Monitors               
• Fetal Electrodes
• Fetal Doppler
• Telemetry Solutions
• Accessories and Consumables
• Software

Portability

• Portable

• Non-portable

Methods

• Non-Invasive

• Invasive

Application

• Intrapartum Fetal Monitoring

• Antepartum Fetal Monitoring

End User

• Hospitals

• Gynaecological/Obstetrics Clinics

• Homecare

• Others

Distribution Channel

• Direct Tender
• Retail

Fetal Monitoring Market Regional Analysis/Insights

The fetal monitoring market is analyzed and market size insights and trends are provided by country, product type, portability, methods, application, end user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to various factors such as technological advancements, increased patient awareness, and improved reimbursement policies. This trend is expected to continue over the forecast period.

Asia-Pacific is expected to witness significant growth during the forecast period due to rising per capita income, ongoing developments in healthcare infrastructure, and favorable government initiatives aimed at improving healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The fetal monitoring market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for fetal monitoring market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the fetal monitoring market. The data is available for historic period 2011-2021.

Competitive Landscape and Fetal Monitoring Market Share Analysis

The fetal monitoring market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the market are:

• Johnson & Johnson Private Limited (U.S.)
• Abbott (U.S.)
• Medtronic (Ireland)
• Boston Scientific Corporation (U.S.)
• B. Braun Melsungen AG (Germany)
• Baxter (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• General Electric (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• Siemens Healthcare GmbH (Germany)
• Analogic Corporation (U.S.)
• Getinge AB (Sweden)
• Natus Medical Incorporated. (Sweden) 
• OSI Systems, Inc. (U.S.)
• Natus Medical Incorporated (U.S.)
• EDAN Instruments, Inc. (China)
• The Cooper Companies Inc. (U.S.)
• MEDGYN PRODUCTS, INC. (U.S.)
• Dixion (Germany)
• Advanced Instruments (U.S.)
• Shenzhen Bestman Instrument Co.,Ltd., (China) 

SKU-1624